Conditional Cytokine Therapeutics for Tumor-Selective Biological Activity Preclinical characterization of a dual-masked IFNα-2b

Erwan Le Scolan, Ph.D., Presented at the Cytokine-Based Cancer Immunotherapies Summit, March 24th, 2021.